Navigation Links
XTENT Announces Clinical Trial Data to be Presented at Annual EuroPCR Meeting Next Week
Date:5/7/2008

vestor relations section of the Company's website at http://investor.xtentinc.com/events.cfm. Please dial in or access the website five to 10 minutes prior to the beginning of the call. If you do dial-in, please also view the slides via the webcast. The webcast will be archived on the website for a minimum of three months, and can be accessed at the investor relations portion of the company's website at http://investor.xtentinc.com

Wednesday, May 14, 2008, 5:00-6:30 p.m. CEST, Room 5

Evening symposium: Customizable drug-eluting stents: a breakthrough approach to the percutaneous treatment of coronary artery disease.

The symposium will provide an overview of the Custom NX DES System with respect to the treatment of long and multi-lesion coronary artery disease, and the CUSTOM clinical program.

Thursday, May 15 12:00-1:30 pm CEST, Room 122/123

EuroIntervention @ EuroPCR: CUSTOM I two-year follow-up results

Eberhard Grube, M.D., Chief of Cardiology at the HELIOS Heart Center in Siegburg, Germany, the principal investigator of the CUSTOM I clinical trial, will present two year follow-up data from the CUSTOM I trial.

About the Custom NX(R) DES System

Custom NX is designed to enable a more personalized approach to the treatment of arterial disease based on each patient's individual lesion characteristics. The Custom NX system allows physicians to customize the length and diameter of the stent at the site of the lesion. The system features a proprietary modular stent design that consists of multiple 6mm cobalt chromium segments coated with Biolimus A9(R) and PLA, a biodegradable drug carrier. The Custom NX delivery system enables separation at each 6mm segment and allows for the placement of up to 60mm of stent.

About XTENT

XTENT, Inc. is a medical device company focused on develop
'/>"/>

SOURCE XTENT, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. XTENT to Present CUSTOM I and CUSTOM II Trial Data at TCT 2007
2. XTENT Announces Positive Two-Year CUSTOM I and One-Year CUSTOM II Trial Data for Novel Drug-Eluting Stent System
3. Study Data Show Asacol(R) (Mesalamine) is Effective in Treating All Extents of Ulcerative Colitis Including Isolated Proctitis
4. XTENT Announces First Quarter 2008 Financial Results
5. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
6. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
7. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
8. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
9. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
10. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
11. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/20/2014)... , Aug. 20, 2014   Easy Breathe , the fastest ... its " Easy Blog " - has received more than 4.5 ... "We are thrilled that so many people are finding ... CEO of Easy Breathe. "We,re committed to making sleep apnea more ... to stay informed about sleep apnea news , troubleshooting ...
(Date:8/20/2014)... Texas , Aug. 20, 2014  Quantum ... five diverse sets of patent families from Bayer Technology ... innovation driver for Bayer AG of Leverkusen, ... patents acquired provide broad intellectual property protection for ... economical high-volume quantum dot (QD) manufacturing. In addition, ...
(Date:8/19/2014)... 19, 2014  The Alabama Supreme Court, in a 6-3 ... drug makers who mislead doctors into believing that prescription medicines ... is Weeks v. Wyeth, and the decision came after the ... case last year. Heninger Garrison Davis attorneys Lew Garrison ... the case, Danny Weeks . The decision ...
Breaking Medicine Technology:Easy Breathe Blog Emerges as the Go-To Resource for Sleep Apnea Sufferers 2Easy Breathe Blog Emerges as the Go-To Resource for Sleep Apnea Sufferers 3Easy Breathe Blog Emerges as the Go-To Resource for Sleep Apnea Sufferers 4Quantum Materials Acquires Bayer Technology Services Quantum Dot Manufacturing and Quantum Dot Solar Cell Patents 2Quantum Materials Acquires Bayer Technology Services Quantum Dot Manufacturing and Quantum Dot Solar Cell Patents 3Quantum Materials Acquires Bayer Technology Services Quantum Dot Manufacturing and Quantum Dot Solar Cell Patents 4Heninger Garrison Davis Clients To Get Their Day in Court Against Brand Drug Companies 2Heninger Garrison Davis Clients To Get Their Day in Court Against Brand Drug Companies 3Heninger Garrison Davis Clients To Get Their Day in Court Against Brand Drug Companies 4
(Date:8/20/2014)... nerve, from which Schwann cells, myelin sheath ... postoperative immune rejection. Simultaneously, chemically extracted acellular ... materials, such as the bottom layer of ... scaffold in the process of nerve regeneration. ... autologous nerve transplantation, can guide nerve regeneration ...
(Date:8/20/2014)... Fresh from the cradle of a world-class ... the starting blocks. , Urbini, a new collection of versatile ... Urbini Avi jogger to its lineup. , The Avi ... look inspired by the latest racing styles and a set ... versatile jogger offers a swift, smooth ride on runs, power-walks ...
(Date:8/20/2014)... August 20, 2014 The National ... five-year, $1.24 million Science Education Partnership Award (SEPA) ... support NAHN’s collaborative project with the Hispanic Communications ... Careers. , This collaborative NIH R25 program has ... and linguistic diversity among health professionals by recruiting ...
(Date:8/20/2014)... Atlantic City, New Jersey (PRWEB) August 20, 2014 ... slow in meeting the needs of an estimated tens ... the introduction of the new Bill A3525—a bill that ... eligible patients to grow their own cannabis—earlier this summer ... proper horticultural training for medicinal quality marijuana is growing. ...
(Date:8/20/2014)... 2014 Verndale is pleased to announce ... an exclusive list ranking the fastest-growing private companies in ... to their yearly percentage revenue growth over a three-year ... the Inc. 5000 list where it ranked number 2,855. ... its clients a wide range of digital marketing services ...
Breaking Medicine News(10 mins):Health News:Urbini Breezes Through Summer with New Jogging Stroller 2Health News:National Association of Hispanic Nurses (NAHN) Receives Five-Year Federal Grant from the National Institutes of Health (NIH) 2Health News:National Association of Hispanic Nurses (NAHN) Receives Five-Year Federal Grant from the National Institutes of Health (NIH) 3Health News:Oaksterdam University to Host Four-Day Educational Marijuana Horticultural Seminar Aug 23-26; Training Fills Information Gap for Medical Marijuana Caregivers and Patients 2Health News:Oaksterdam University to Host Four-Day Educational Marijuana Horticultural Seminar Aug 23-26; Training Fills Information Gap for Medical Marijuana Caregivers and Patients 3Health News:For the 8th Time, Verndale Has Been Honored on the Inc. 5000 List 2
... used synthetic progestin medroxyprogesterone acetate (MPA) decreased endothelial function ... University of Oregon. The finding, researchers said, raises concerns ... hormones on vascular health in young women. , The ... recent years, it has been found to be a ...
... Innovative design allows snap-on rod attachment and self-alignment ... ... Life Spine announced,today that the U.S. Food and Drug Administration ... system designed for,use in surgical lumbar fusion procedures., Life Spine,s ...
... care industry expertise has led Precyse to a leadership role, ... Operating ... WAYNE, Pa., March 10 Precyse Solutions, the leader ... the appointment of Ken Lacy as Senior Vice,President and Chief ...
... March 10 NBTY, Inc. (NYSE:,NTY) (http://www.NBTY.com ), ... announced that it will web cast the,presentation by Harvey ... Bank of America Consumer Conference in New York on ... be web cast live on the Company Web,site, ...
... precise control of ... key to averting brain damage, LOUISVILLE, Colo., March 10 ... most effective cooling technology-the,non- invasive Arctic Sun(R)-is increasing rapidly. The ... ill,patients with the Arctic Sun rose to more than 72 ...
... abnormal Pap test results happened after girls and women were ... researcher at the University of Alabama at Birmingham (UAB). , ... the development of cell changes that lead to cervical disease, ... test results by 43 percent compared to women not given ...
Cached Medicine News:Health News:Oregon study raises questions on synthetic progestins 2Health News:Oregon study raises questions on synthetic progestins 3Health News:Life Spine Adds New Lynx(TM) Cross Connector to Its Lumbar Fixation Offering 2Health News:Precyse Solutions Promotes Ken Lacy to Senior Vice President & CIO to Drive Advancement of PrecyseNet(TM), Precyse's Advanced Technology Solution 2Health News:NBTY to Webcast Presentation at Bank of America Consumer Conference: Announces Preliminary Sales and the Repurchase of 6.1 Million Shares 2Health News:NBTY to Webcast Presentation at Bank of America Consumer Conference: Announces Preliminary Sales and the Repurchase of 6.1 Million Shares 3Health News:More than Seventy Percent of Top US Hospitals Control Patient Temperature with High-Tech Arctic Sun(TM) 2Health News:HPV vaccine reduces abnormal pap test results 2
... CMIS Telemetry System is a telemetry ... hospitals which require monitoring and performance. ... are able to monitor patients from ... transmitters and wireless bedsides. Now, monitoring ...
... Telemetry System, portable TeleMon companion monitor, ... integrated surveillance and monitoring solution for ... of ECG and SpO2. Clinicians can ... patient information from the central station, ...
TeleRehab Advantage is a monitoring system that automates the generation of outcomes data. Patient information and session information is automatically transferred from the monitoring program to Outc...
ISI DuraHand is the reusable, easy to sterilize surgical hand immobilizer....
Medicine Products: